148 related articles for article (PubMed ID: 6981182)
41. Circulating immune complexes and rheumatoid arthritis: a comparison of different assay methods and their early predictive value for disease activity and outcome.
Reeback JS; Silman AJ; Holborow EJ; Maini RN; Hay FC
Ann Rheum Dis; 1985 Feb; 44(2):79-82. PubMed ID: 3872100
[TBL] [Abstract][Full Text] [Related]
42. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
Krieger G; Kneba M; Bolz I; Volling P; Wessels J; Nagel GA
J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
[TBL] [Abstract][Full Text] [Related]
43. Clinical utility of assays for circulating immune complexes.
Endo L; Corman LC; Panush RS
Med Clin North Am; 1985 Jul; 69(4):623-36. PubMed ID: 3903373
[TBL] [Abstract][Full Text] [Related]
44. Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor.
Jordon RE; Struve MF; Bushkell LL
Clin Exp Immunol; 1981 Jul; 45(1):29-36. PubMed ID: 7030538
[TBL] [Abstract][Full Text] [Related]
45. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
Sjöholm AG; Berglund K; Johnson U; Laurell AB; Sturfelt G
Int Arch Allergy Appl Immunol; 1986; 79(2):113-9. PubMed ID: 3484727
[TBL] [Abstract][Full Text] [Related]
46. [Circulating immune complexes: optimization and characteristics of the C1q(I125) fixation test].
Caillot G; Lamelin JP; Hartmann DJ; Ville G
Pathol Biol (Paris); 1984 Nov; 32(9):931-7. PubMed ID: 6334270
[TBL] [Abstract][Full Text] [Related]
47. Failure to find C1q-binding material and anti-IgG antibodies in ankylosing spondylitis.
Duquesnoy B; Santoro F; Wattre P; Delcambre B
Ann Rheum Dis; 1980 Oct; 39(5):449-52. PubMed ID: 6969066
[TBL] [Abstract][Full Text] [Related]
48. Circulating immune complexes in human acute leukaemia.
Balestrieri G; Tincani A; Cattaneo R; Rossi G; Verzura P; Marini G; Calculli G; Ferremi P; Marinone G
Br J Haematol; 1981 Oct; 49(2):269-74. PubMed ID: 6975116
[TBL] [Abstract][Full Text] [Related]
49. Detection & characterization of immune complexes in the sera of ankylosing spondylitis patients.
Kapoor AK; Agarwal RR; Siddiqui JS; Bhushan V; Jain UK; Khan IU; Gupta AK; Singh GK
Indian J Med Res; 1985 Nov; 82():447-51. PubMed ID: 4093163
[No Abstract] [Full Text] [Related]
50. Effects of single-stranded DNA on circulating immune complexes in SLE sera detected by C1q solid-phase assay.
Furukawa F; Sekita K; Muso E; Imamura S; Hamashima Y
Arch Dermatol Res; 1985; 277(1):71-4. PubMed ID: 3871602
[No Abstract] [Full Text] [Related]
51. Investigation of the recommended use of anti-Clq for reducing non-specific reactions in solid-phase C1q assays for circulating immune complexes.
Wainer EM; Schepers G; Schweizer K; Pusztai-Markos Z
J Immunol Methods; 1984 Jan; 66(1):193-5. PubMed ID: 6363550
[No Abstract] [Full Text] [Related]
52. A new method for the detection of circulating immune complexes by immunoelectrophoretic analysis. II. Studies on human pathological and normal sera.
Swierczyńska Z; Woźniczko-Orłowska G; Rdułtowska H
Reumatologia; 1979; 17(3):279-84. PubMed ID: 515571
[No Abstract] [Full Text] [Related]
53. Circulating C1q binding immune complexes in relatives of patients with systemic lupus erythematosus.
Elkon KB; Walport MJ; Rynes RI; Black CM; Batchelor JR; Hughes GR
Arthritis Rheum; 1983 Jul; 26(7):921-4. PubMed ID: 6603223
[No Abstract] [Full Text] [Related]
54. Relation of microscopic haematuria in ankylosing spondylitis to circulating IgA containing immune complexes.
Peeters AJ; van den Wall Bake AW; van Dalsen AD; Westedt ML
Ann Rheum Dis; 1988 Aug; 47(8):645-7. PubMed ID: 3415363
[TBL] [Abstract][Full Text] [Related]
55. Statistical analysis of five immune complex screening assays: patterns of detection in patients with rheumatoid arthritis, systemic lupus erythematosus, infectious endocarditis, and diabetes mellitus.
Kilpatrick JM; Virella G
Diagn Immunol; 1983; 1(2):57-63. PubMed ID: 6388965
[TBL] [Abstract][Full Text] [Related]
56. [Methods of determining circulating immune complexes].
Baleva M
Vutr Boles; 1983; 22(6):1-5. PubMed ID: 6369791
[No Abstract] [Full Text] [Related]
57. Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.
Bruneau C; Bonin H
Clin Exp Immunol; 1983 Sep; 53(3):529-35. PubMed ID: 6616954
[TBL] [Abstract][Full Text] [Related]
58. Circulating immune complexes and autoantibodies in lung cancer.
Guy K; Di Mario U; Irvine WJ; Hunter AM; Hadley A; Horne NW
Br J Cancer; 1981 Mar; 43(3):276-83. PubMed ID: 7225280
[TBL] [Abstract][Full Text] [Related]
59. Circulating immune complexes detected by C1q solid phase assay in leprosy.
Nuti M; D'Amelio R; Seminara R; Milano CF; Palmisano L; Aiuti F
Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):27-30. PubMed ID: 6972924
[TBL] [Abstract][Full Text] [Related]
60. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
